VRNM Share Price

Open 3.99 Change Price %
High 4.00 1 Day 0.01 0.25
Low 3.97 1 Week 0.00 0.00
Close 3.99 1 Month 0.00 0.00
Volume 342357 1 Year 0.00 0.00
52 Week High 2.85
52 Week Low 0.76
VRNM Important Levels
Resistance 2 4.02
Resistance 1 4.01
Pivot 3.99
Support 1 3.97
Support 2 3.96
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
More..
NASDAQ USA Top Gainers Stocks
AMCF 0.02 100.00%
RITT 0.02 100.00%
LOCM 0.09 50.00%
SCHS 0.04 33.33%
GEVO 0.81 32.79%
MRGE 0.55 30.95%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
CYCC 2.24 21.74%
More..
NASDAQ USA Top Losers Stocks
CAFI 0.00 -100.00%
EDMC 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Verenium Corporation (NASDAQ: VRNM)

VRNM Technical Analysis 5
As on 31st Oct 2013 VRNM Share Price closed @ 3.99 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.60 & Strong Buy for SHORT-TERM with Stoploss of 3.34 we also expect STOCK to react on Following IMPORTANT LEVELS.
VRNM Target for September
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
VRNM Other Details
Segment EQ
Market Capital 31766280.00
Sector Basic Industries Major Chemicals
Industry
Offical website
VRNM Address
VRNM
N/A
VRNM Latest News
Interactive Technical Analysis Chart Verenium Corporation ( VRNM NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Verenium Corporation
VRNM Business Profile
Verenium Corporation (Verenium) is an industrial biotechnology company. The Company develops and commercializes enzymes for use in a range of industrial processes. It manufactures and markets its enzyme products in the fields of animal health and nutrition, grain processing, oilfield services and other industrial processes, such as pulp and paper and textiles. As of December 31, 2012, it marketed commercial enzyme products, either independently or in collaboration with its partners. In addition, it has developed a pipeline of enzyme product candidates. Its products are organized into four product lines: animal health and nutrition, grain processing, oilfield services and other industrial processes. As of December 31, 2012, it markets nine commercial enzyme products. In October 2013, BASF SE acquired 71% stake in the Company.